Search
Showing results for "1"
Our team aims to optimise lung health early in life to ensure the best possible health outcomes later in life.
We aim to discover and develop safer and more effective treatments by doing inventive and rigorous research to improve outcomes for kids with cancer.
Adaptive clinical trials have designs that evolve over time because of changes to treatments or changes to the chance that participants will receive these treatments. These changes might introduce confounding that biases crude comparisons of the treatment arms and makes the results from standard reporting methods difficult to interpret for adaptive trials. To deal with this shortcoming, a reporting framework for adaptive trials was developed based on concurrently randomised cohort reporting.
Parents of children living with rare chronic and complex diseases have called for better education and resourcing of health professionals
Heatwaves have serious health impacts and we need a better approach to prevention and management
Fiona Stanley FAA FASSA MSc MD FFPHM FAFPHM FRACP FRANZCOG HonDSc HonDUniv HonFRACGP HonMD HonFRCPCH HonLLB (honoris causa) Patron 08 6319 1176
determining if regular consumption of egg protein from age 4 to 6 months reduces the risk of IgE mediated allergy in infants with genetic risk, without eczema.
The burden of cardiovascular diseases (CVDs) remains unclear in many regions of the world.
We aimed to determine whether regular consumption of egg protein from 4-6 month old reduced the risk of IgE-mediated egg allergy in infants without eczema.
Overall the analyses do not suggest individual sequence variants account for differences in clinical outcome or adaptation to different hosts.